WebIXX Jornadas del comité de Graduados SAD, octubre 2024 Tema: “Diabetes y órganos no clásicos”. Mesa 3: Complicaciones de la diabetes en piel, músculo, hueso y articulaciones Web3 apr. 2024 · The main symptoms of bullous pemphigoid are blisters appearing on the skin, which occur normally in areas where the skin flexes or bends. There can be other symptoms like patches of itchy skin or a …
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a …
Web28 feb. 2024 · Bullous pemphigoid (BP) is an autoimmune bullous disease caused by circulating autoantibodies toward the hemidesmosomal antigens BP180 and BP230. Cases of BP have been described following vaccinations against tetanus, poliomyelitis, diphtheria, influenza, pneumococcus, meningococcus, hepatitis B and rabies. Web13 apr. 2024 · Pemphigoid diseases typically manifest with blistering of the skin and mucous membranes and are associated with autoantibodies that target structural proteins of the hemidesmosome. Specific disorders are described within the pemphigoid spectrum, and it is important to distinguish the variants because medical implications and … head and shoulders supreme volume
Drug-induced bullous pemphigoid in diabetes mellitus
WebWe found an association between treatment with metformin and recalcitrant BP (defined as BP requiring the addition of a steroid-sparing agent to achieve BP control), whereas treatment with sulfonylurea showed a trend for association with recalcitrant BP that did not reach statistical significance. Web16 jul. 2011 · Bullous pemphigoid (BP) is an autoimmune disorder characterized by the production of autoantibodies against two antigens (BPAG1 and 2) and can be induced by drugs ( 1, 2 ). Recently, the development of BP was reported in diabetic patients treated with dipeptidyl peptidase-4 inhibitors (gliptins) plus metformin ( 3 ). Web5 mrt. 2024 · On The Spanish Pharmacovigilance System for Human Use Drugs, we conducted a bullous pemphigoid-metformin association analysis within the period 1982–2024. Main outcome measure Adverse reaction cases in pharmacovigilance databases and the disproportionality through the reporting odds ratio. gold glove charities